Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2

Clinical and Experimental Immunology

Volumn 173, Issue 3, 2013, Pages 502-511

  Ostvik A E ^a,b   Granlund, A V B ^a   Torp, S H ^a,b   Flatberg, A ^a   Beisvag V ^a   Waldum, H L ^a,b   Flo, T H ^a   Espevik, T ^a   Damas J K ^a,b   Sandvik, A K ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Crohn's disease; Inflammatory bowel disease; Lipocalin 2; TLR 3; Ulcerative colitis

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN; INTERLEUKIN 1BETA; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3;

ADULT; AGED; ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; DISEASE CONTROL; ENTERITIS; EPITHELIUM CELL; FECES ANALYSIS; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MESSENGER RNA SYNTHESIS; MICROARRAY ANALYSIS; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; ULCERATIVE COLITIS;

CROHN'S DISEASE; INFLAMMATORY BOWEL DISEASE; LIPOCALIN 2; TLR-3; ULCERATIVE COLITIS;

ACUTE-PHASE PROTEINS; ADULT; AGED; BIOPSY; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; HT29 CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LIPOCALINS; MALE; MIDDLE AGED; POLY I-C; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; TOLL-LIKE RECEPTOR 3; YOUNG ADULT;

EID: 84881500778     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12136     Document Type: Article

References (30)

1. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361:2066-2078.
2. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 2004; 118:229-241.
3. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474:298-306.
4. Muniz LR, Knosp C, Yeretssian G. Intestinal antimicrobial peptides during homeostasis, infection, and disease. Front Immunol 2012; 3:310; 1-10.
5. Wehkamp J, Schmid M, Fellermann K, Stange EF. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J Leukoc Biol 2005; 77:460-465.
6. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002; 10:1033-1043.
7. Flo TH, Smith KD, Sato S etal. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004; 432:917-921.
8. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993; 268:10425-10432.
9. Cowland JB, Sorensen OE, Sehested M, Borregaard N. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 2003; 171:6630-6639.
10. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 1996; 38:414-420.
11. Bu DX, Hemdahl AL, Gabrielsen A etal. Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB. Am J Pathol 2006; 169:2245-2253.
12. Eagan TM, Damas JK, Ueland T etal. Neutrophil gelatinase-associated lipocalin: a biomarker in COPD. Chest 2010; 138:888-895.
13. Oikonomou KA, Kapsoritakis AN, Theodoridou C etal. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity. J Gastroenterol 2012; 47:519-530.
14. Nielsen OH, Gionchetti P, Ainsworth M etal. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis. Am J Gastroenterol 1999; 94:2923-2928.
15. Ostvik AE, Vb Granlund A, Bugge M etal. Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation. Inflamm Bowel Dis 2013; 19:265-274.
16. Landro L, Damas JK, Flo TH etal. Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy. Clin Exp Immunol 2008; 152:57-63.
17. Granlund AB, Beisvag V, Torp SH etal. Activation of REG family proteins in colitis. Scand J Gastroenterol 2011; 46:1316-1323.
18. Sen GC, Sarkar SN. Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev 2005; 16:1-14.
19. Dooley TP, Curto EV, Reddy SP etal. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis 2004; 10:1-14.
20. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001; 10:445-456.
21. Csillag C, Nielsen OH, Vainer B etal. Expression of the genes dual oxidase 2, lipocalin 2 and regenerating islet-derived 1 alpha in Crohn's disease. Scand J Gastroenterol 2007; 42:454-463.
22. Borregaard N, Sehested M, Nielsen BS, Sengelov H, Kjeldsen L. Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood 1995; 85:812-817.
23. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68:7010-7017.
24. Furrie E, Macfarlane S, Thomson G, Macfarlane GT. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 2005; 115:565-574.
25. Xu J, Yang Y, Wang C, Jiang B. Rotavirus and coxsackievirus infection activated different profiles of toll-like receptors and chemokines in intestinal epithelial cells. Inflamm Res 2009; 58:585-592.
26. Vijay-Kumar M, Wu H, Aitken J etal. Activation of Toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm Bowel Dis 2007; 13:856-864.
27. Cavassani KA, Ishii M, Wen H etal. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 2008; 205:2609-2621.
28. Zhou R, Wei H, Sun R, Tian Z. Recognition of double-stranded RNA by TLR3 induces severe small intestinal injury in mice. J Immunol 2007; 178:4548-4556.
29. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279:12542-12550.
30. Chassaing B, Srinivasan G, Delgado MA, Young AN, Gewirtz AT, Vijay-Kumar M. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS ONE 2012; 7:e44328.